Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stamatis-Nick C Liossis

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Clinical Immunology (Orlando, Fla.)|April 18, 2024
The abnormal signaling of the B cell receptor and co-receptors of lupus B cellsStamatis-Nick C Liossis
International Archives of Allergy and Immunology|January 17, 2004
B lymphocyte selection and survival in systemic lupusStamatis-Nick C Liossis, Moncef Zouali
Frontiers in Medicine|July 21, 2022
The Role of B Cells in Scleroderma Lung Disease PathogenesisStamatis-Nick C Liossis, Chrysanthi Staveri
Current Rheumatology Reports|November 5, 2017
B Cell-Based Treatments in SLE: Past Experience and Current DirectionsStamatis-Nick C Liossis, Chrysanthi Staveri
Expert Opinion on Pharmacotherapy|March 5, 2014
Molecular abnormalities of the B cell in systemic lupus erythematosus are candidates for functional inhibition treatmentsStamatis-Nick C Liossis, Konstantinos Melissaropoulos
Arthritis Research & Therapy|March 11, 2014
B cells tell scleroderma fibroblasts to produce collagenDimitrios Daoussis, Stamatis-Nick C Liossis
Mediterranean Journal of Rheumatology|June 12, 2020
From Basic Immunology to Clinical Practice: Bio-Originators versus Bio-SimilarsStamatis-Nick C Liossis, Georgia M Konstantopoulou
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|March 30, 2004
Costimulation blockade in the treatment of rheumatic diseasesStamatis-Nick C Liossis, Petros P Sfikakis
Mediterranean Journal of Rheumatology|May 25, 2022
B Cell Depletion Treatment in Resistant Systemic Sclerosis Interstitial Lung DiseaseConstantina A Bounia, Stamatis-Nick C Liossis
Expert Opinion on Investigational Drugs|March 7, 2008
The future of the IL-1 receptor antagonist anakinra: from rheumatoid arthritis to adult-onset Still's disease and systemic-onset juvenile idiopathic arthritisGeorge D Kalliolias, Stamatis-Nick C Liossis
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Clinical Immunology (Orlando, Fla.)|April 18, 2024
The abnormal signaling of the B cell receptor and co-receptors of lupus B cellsStamatis-Nick C Liossis
International Archives of Allergy and Immunology|January 17, 2004
B lymphocyte selection and survival in systemic lupusStamatis-Nick C Liossis, Moncef Zouali
Frontiers in Medicine|July 21, 2022
The Role of B Cells in Scleroderma Lung Disease PathogenesisStamatis-Nick C Liossis, Chrysanthi Staveri
Current Rheumatology Reports|November 5, 2017
B Cell-Based Treatments in SLE: Past Experience and Current DirectionsStamatis-Nick C Liossis, Chrysanthi Staveri
Expert Opinion on Pharmacotherapy|March 5, 2014
Molecular abnormalities of the B cell in systemic lupus erythematosus are candidates for functional inhibition treatmentsStamatis-Nick C Liossis, Konstantinos Melissaropoulos
Arthritis Research & Therapy|March 11, 2014
B cells tell scleroderma fibroblasts to produce collagenDimitrios Daoussis, Stamatis-Nick C Liossis
Mediterranean Journal of Rheumatology|June 12, 2020
From Basic Immunology to Clinical Practice: Bio-Originators versus Bio-SimilarsStamatis-Nick C Liossis, Georgia M Konstantopoulou
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|March 30, 2004
Costimulation blockade in the treatment of rheumatic diseasesStamatis-Nick C Liossis, Petros P Sfikakis
Mediterranean Journal of Rheumatology|May 25, 2022
B Cell Depletion Treatment in Resistant Systemic Sclerosis Interstitial Lung DiseaseConstantina A Bounia, Stamatis-Nick C Liossis
Expert Opinion on Investigational Drugs|March 7, 2008
The future of the IL-1 receptor antagonist anakinra: from rheumatoid arthritis to adult-onset Still's disease and systemic-onset juvenile idiopathic arthritisGeorge D Kalliolias, Stamatis-Nick C Liossis
Pageof 5